SCHEMBL3223036

SCHEMBL3223036

CSc1ccc(C(O)c2cc(Br)c(OCc3ccccc3)cc2C)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALOX5 P09917 4/20 0.37
GCK P35557 2/20 0.37
MAPT P10636 2/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
PTGER1 P34995 1/20 0.35
CCR5 P51681 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
TLR9 Q9NR96 1/20 0.34
LIPE Q05469 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3223738 0.86 SMN1; SMN2 (0.39) RAB9ASMN1; SMN2MAPTMAPK1TDP1
SCHEMBL21557913 0.85 LMNA (0.44) RAB9ASMN1; SMN2MAPTL3MBTL1KEAP1
SCHEMBL21551795 0.83 MAPT (0.42) RAB9ASMN1; SMN2ALOX5MAPTKEAP1
SCHEMBL20140068 0.81 HTR2A (0.42) RAB9ASMN1; SMN2MAPTMAPK1TDP1
SCHEMBL2577600 0.81 LIPE (0.43) ALOX5GCKMAPTMAPK1TDP1
SCHEMBL2174329 0.79 FFAR4 (0.36) RAB9ASMN1; SMN2MAPTHTR2AHTR2C
SCHEMBL23700114 0.79 MAOB (0.46) RAB9ASMN1; SMN2MAPTHTR2AHTR2C
SCHEMBL3223812 0.77 SLC6A2 (0.41) RAB9ASMN1; SMN2GCKMAPTMAPK1
SCHEMBL17659021 0.75 MAPT (0.53) RAB9ASMN1; SMN2MAPTMAPK1TDP1
SCHEMBL20741981 0.74 TDP1 (0.44) RAB9ASMN1; SMN2MAPTMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069460-A1 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2010-03-18 US disclosed
EP-2103607-A1 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2009-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069460-A1 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE SLC5A1, SLC5A2, SLC2A1 RAB9A 3641/4885SMN1; SMN2 4236/4885ALOX5 3117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.